Zuranolone a reliable drug for post partum depression

Written By :  Roshni Dhar
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-07-31 04:15 GMT   |   Update On 2023-07-31 10:43 GMT

Most new mothers experience postpartum "#depression #babyblues #postpartumdepressionMost new mothers experience postpartum & baby blues& after childbirth, which commonly include mood swings, crying spells, anxiety and difficulty sleeping. Baby blues usually begin within the first 2 to 3 days#depression #babyblues #postpartumdepressionMost new mothers experience postpartum &...

Login or Register to read the full article

Most new mothers experience postpartum "#depression #babyblues #postpartumdepression

Most new mothers experience postpartum & baby blues& after childbirth, which commonly include mood swings, crying spells, anxiety and difficulty sleeping. Baby blues usually begin within the first 2 to 3 days#depression #babyblues #postpartumdepression

Most new mothers experience postpartum & baby blues& after childbirth, which commonly include mood swings, crying spells, anxiety and difficulty sleeping. Baby blues usually begin within the first 2 to 3 days" after childbirth, which commonly include mood swings, crying spells, anxiety and difficulty sleeping. Baby blues usually begin within the first 2 to 3 days after delivery and may last for up to two weeks.

A pill for postpartum depression led to meaningful improvements in depression symptoms, according to a late-stage study published Wednesday in The American Journal of Psychiatry.

The pill, zuranolone, is not yet approved, but the Food and Drug Administration is expected to make its approval decision by Aug 5.

In the current study included 196 mothers who experienced postpartum depression were split into two groups - half were zuranolone, half given placebo pills for two weeks.

All of the mothers experienced an improvement in their depression symptoms, but those

Gfx on video- Taking the real medication experienced significantly better improvements than those who got the placebo pills

Reference: Kristina M. Deligiannidis,M.D., Samantha Meltzer-Brody et al; Zuranolone for the Treatment of Postpartum Depression, 26 Jul 2023https://doi.org/10.1176/appi.ajp.20220785.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News